Misc
An Overview of Clinical Overview
A Clinical Overview is an integrated document intended to provide critical analysis of Pharmacology Efficacy and Safety of the pharmaceutical agent in humans It is one of the important documents of Module of the Common Technical Document CTD ie Module which refers to the data provided in the comprehensive clinical summary the individual clinical...
BIOLOGICS AND BIOSIMILARS MARKET
Key trends in 2021
The first Biosimilar was approved in the year in the European Union and since then there have been more than biosimilar drugs that have been approved Not surprisingly there has been phenomenal growth in the biosimilars market an Assocham report states that the global biosimilars market is estimated to reach US billion by while the Indian biosimi...
COMBINING SAFETY AND EFFICIENCY IN RECONSTITUTED DRUGS IN THE FAR EAST MARKETS
Can advanced dual-chamber solutions help?
Latest figures show that China is the second pharmaceutical market in the world after the United States with an overall value amounting to about billion dollars in
China’s New PRC Biosecurity Law
Key implications for international players
Against the background of the COVID global pandemic China fasttracked and passed last year its first national biosecurity law Biosecurity Law The law which took effect on April of this year adds another key component to Chinas overall national security
PRACTICE MAKES PERFECT
Adopting industry best practice requires three critical skills
Every life science company is eager to find and absorb industry best practices and for good reason In a business environment that is changing quickly no firm can afford to be left behind and relying on internal experience and lessons is too slow It is essential to imitate as well as to innovate
MODELLING SUCCESS
What is a business model, and how can you build one?
As companies from Roche to Merck demonstrate successful adaptation begins with a shared vision of the future business model But therein lies the problem What is a business model Despite it being peppered over every meeting and filling the media there is no agreement amongst either academics or executives about the definition of this ubiquitous term
2022 TRENDS IN PHARMA MARKETING
Its been nearly two years since the outbreak of COVID began and were still in the midst of enormous disruptions to the worlds economies businesses education and peoples lives
